Article

Join the Conversation About Oncology Nurses

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Oncology nurses are on the front line of patient care, and last week, at the Oncology Nursing Society (ONS) Annual Congress, we reported on the ever-growing nursing role and recent research coming out in how they can more effectively treat patients with cancer.

Join us and our sister publication, Oncology Nursing News, for an #OncNurseConnect tweet chat on Wednesday, May 22 at 1:00 EST to discuss highlights from the conference. We want to hear about your wonderful stories with oncology nurses, as well as your patient experiences on new treatments and their side effects that were covered throughout the meeting.

To participate, follow @OncNursingNews, which will be tweeting out the questions. Once the question is asked, just join in and remember to use the #OncNurseConnect hashtag.

We hope to see you there!

Related Videos
Image of doctor with grey hair.
Image of doctor with black hair.
Dr. Alan Tan is a genitourinary oncology (GU) and melanoma specialist at the Vanderbilt-Ingram Cancer Center in Nashville, Tennessee; an associate professor of medicine in the Division of Hematology and Oncology at Vanderbilt University Medical Center; and GU Executive Officer with the Alliance for Clinical Trials in Oncology.
Dr. Chandler Park, a medical oncologist of Genitourinary Medical Oncology, at the Norton Healthcare Institute, in Louisville, Kentucky.
Image of woman with blonde hair.
Image of woman with blonde hair.
Image of woman with brown hair.
Related Content
Image of man with doctor.
March 14th 2025

PSMA-PET Improves Detection of Metastases in High-Risk Prostate Cancer

Ryan Scott
Investigators found that some patients with high-risk nonmetastatic hormone-sensitive prostate cancer were understaged by conventional imaging.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
September 20th 2024

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
Illustration of bladder cancer.
March 14th 2025

Blue Light Cystoscopy Reduces Recurrence in High-Risk Bladder Cancer

Ryan Scott
Blue light cystoscopy had a statistically significant reduction in risk of recurrence versus white light cystoscopy in high-risk bladder cancer.
cancer horizons logo: a white microphone on a navy blue background
March 11th 2024

Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Alex Biese Brielle Benyon
Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma.
Illustration of bladder.
March 13th 2025

Antihistamines Associated With Bladder Cancer Survival, Progression Improvements

Alex Biese
Antihistamines are associated with improvement for patients with metastatic urothelial carcinoma receiving Tecentriq.
Illustration of woman with blonde hair.
March 13th 2025

Trusting My Stage 4 Breast Cancer Body

Martha Carlson
Practicing consistency has made a difference for me while living with stage 4 breast cancer.